Vaxxinity, Inc. (VAXX)
0.015
0.00 (0.00%)
USD |
OTCM |
Sep 08, 16:00
Vaxxinity Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.131 |
| September 30, 2023 | 0.5614 |
| June 30, 2023 | 0.3922 |
| March 31, 2023 | 0.3032 |
| December 31, 2022 | 0.234 |
| September 30, 2022 | 0.1298 |
| June 30, 2022 | 0.108 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.0941 |
| December 31, 2021 | 0.0832 |
| September 30, 2021 | 0.1153 |
| June 30, 2021 | 0.103 |
| March 31, 2021 | 0.2025 |
| December 31, 2020 | -1.538 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.956 |
| Oncolytics Biotech, Inc. | -0.0726 |
| Sangamo Therapeutics, Inc. | -1.020 |
| Sarepta Therapeutics, Inc. | 0.6845 |
| Anixa Biosciences, Inc. | 0.0127 |